Summary & Overview
HCPCS J2305: Injection, Nitroglycerin 5 mg
HCPCS Level II code J2305 designates a 5 mg injectable dose of nitroglycerin, a short-acting vasodilator used in acute cardiovascular settings. Nationally, this code matters for hospital, emergency department, and observation unit billing where parenteral nitroglycerin is administered for chest pain, acute coronary syndromes, hypertensive emergencies, or other indications requiring rapid hemodynamic effect. Accurate use of J2305 affects facility charge capture and payer reimbursement for injectable medication services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what J2305 represents clinically and operationally, guidance on typical sites of service, and an outline of the common modifiers associated with injectable drug billing. The publication also summarizes benchmarking and reimbursement considerations across major national payers where available, and highlights clinical context relevant to billing decisions.
This resource is intended for billing managers, revenue cycle staff, clinical coders, and policy analysts seeking a national perspective on HCPCS Level II code J2305 and its role in facility billing for injectable nitroglycerin.
Billing Code Overview
HCPCS Level II code J2305 describes an injection of nitroglycerin, 5 mg. This code represents a single-dose parenteral administration of nitroglycerin intended for rapid vasodilatory effect.
Service type: injectable medication administration
Typical site of service: hospital inpatient, emergency department, and observation units where parenteral nitroglycerin is administered for acute ischemic or hypertensive conditions.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department or inpatient ward with acute chest pain, hypertensive crisis with ischemic symptoms, or suspected acute coronary syndrome where rapid coronary vasodilation is required. The clinician orders J2305 (injection, nitroglycerin, 5 mg) for short-term intravenous nitrate therapy when sublingual or transdermal nitrates are ineffective, not feasible, or when precise titratable IV dosing is required. Workflow: triage and initial assessment (history, vitals, ECG, cardiac biomarkers), intravenous access placement, baseline hemodynamic monitoring, pharmacy or authorized clinician prepares and documents the J2305 injection dose, nurse administers under protocol with continuous blood pressure and heart rate monitoring, reassess chest pain and hemodynamics, and document response and any adverse effects (hypotension, headache, reflex tachycardia). Typical sites of service include hospital emergency departments, inpatient hospital units, intensive care units, and occasionally ambulatory infusion centers under direct physician supervision.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When complexity or time for administration/documentation is substantially greater than usual |